{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T17:23:34Z","timestamp":1794504214701,"version":"4.9.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"8124","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,7,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Gliomas with mutant isocitrate dehydrogenase (IDH) are malignant brain tumours that typically arise in early to mid-adulthood and nearly always recur following treatment\n                    <jats:sup>1,2<\/jats:sup>\n                    . However, the genetic and cellular-state changes that drive IDH-mutant glioma progression under treatment remain incompletely understood. Here we integrated single-nucleus transcriptomic profiles, chromatin accessibility profiles and bulk DNA and RNA sequencing from 75 temporally separated gliomas across 35 patients comprising both the oligodendroglioma and astrocytoma IDH-mutant glioma tumour types. We show that malignant cell states transcriptionally resemble stages of normal glial\u2013neuronal lineage development or a reactive mesenchymal-like state, mirroring states previously described in IDH wild-type glioblastoma\n                    <jats:sup>3,4<\/jats:sup>\n                    . Malignant cell states displayed distinct chromatin accessibility profiles that were comparable between both IDH-mutant glioma types. The abundance of less differentiated malignant cells increased with grade and with genetic alterations such as\n                    <jats:italic>PDGFRA<\/jats:italic>\n                    amplification. Longitudinal analysis highlighted two major malignant cell-state transition patterns. First, reduced lineage differentiation and increased proliferative malignant cells at recurrence were enriched in gliomas that acquired recurrence-associated genetic events. These included treatment-associated hypermutation, increased copy number changes and cell cycle alterations. Second, increased mesenchymal-like-state abundance occurred independently of acquired genetic alterations and instead coincided with elevated macrophage expression. Overall, our findings provide an integrative model that traces the cell intrinsic and extrinsic factors that shape cellular states during IDH-mutant glioma disease progression.\n                  <\/jats:p>","DOI":"10.1038\/s41586-026-10612-6","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:03:29Z","timestamp":1780499009000},"page":"1048-1059","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Acquired genetic and cell-state changes in IDH-mutant glioma progression"],"prefix":"10.1038","volume":"655","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0016-5158","authenticated-orcid":false,"given":"Kevin C.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6551-9338","authenticated-orcid":false,"given":"Avishay","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6307-016X","authenticated-orcid":false,"given":"Frederick S.","family":"Varn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6095-7849","authenticated-orcid":false,"given":"Masashi","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8582-0865","authenticated-orcid":false,"given":"Luciano","family":"Garofano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6747-6316","authenticated-orcid":false,"given":"Tamrin","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9668-6048","authenticated-orcid":false,"given":"Anuja","family":"Lipsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester Calvo","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanyeri","family":"Barak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2838-3341","authenticated-orcid":false,"given":"A.","family":"Gulhan Ercan-Sencicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse Buket","family":"Peksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2362-273X","authenticated-orcid":false,"given":"Kevin J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3541-9242","authenticated-orcid":false,"given":"C. Mircea S.","family":"Tesileanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3207-9505","authenticated-orcid":false,"given":"Samirkumar B.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Kocakavuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dacheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4940-4693","authenticated-orcid":false,"given":"Fulvio","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Migliozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5469-3816","authenticated-orcid":false,"given":"Lillian","family":"Bussema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gritsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Eun","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3007-8653","authenticated-orcid":false,"given":"Sun Ha","family":"Paek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6564-6388","authenticated-orcid":false,"given":"Franck","family":"Bielle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0058-3176","authenticated-orcid":false,"given":"Alice","family":"Laurenge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Luisa","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9182-5846","authenticated-orcid":false,"given":"Bertrand","family":"Mathon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Picca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Sanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4412-2355","authenticated-orcid":false,"given":"Ann-Christin","family":"Hau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Hertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Grzyb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8945-9632","authenticated-orcid":false,"given":"Zheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3488-1059","authenticated-orcid":false,"given":"Qianghu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8225-241X","authenticated-orcid":false,"given":"Hiroaki","family":"Wakimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Moliterno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2290-7055","authenticated-orcid":false,"given":"Murat","family":"G\u00fcnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Hermes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Sanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4160-2521","authenticated-orcid":false,"given":"Anna","family":"Golebiewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3417-9534","authenticated-orcid":false,"given":"Simone P.","family":"Niclou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Huse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1669-0793","authenticated-orcid":false,"given":"W. K.","family":"Alfred Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lasorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9898-5351","authenticated-orcid":false,"given":"Mario L.","family":"Suv\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0683-4634","authenticated-orcid":false,"given":"Antonio","family":"Iavarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5477-2987","authenticated-orcid":false,"given":"Itay","family":"Tirosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2773-0436","authenticated-orcid":false,"given":"Roel G. W.","family":"Verhaak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"10612_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N. et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 23, 1231\u20131251 (2021).","journal-title":"Neuro Oncol."},{"key":"10612_CR2","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","volume":"25","author":"QT Ostrom","year":"2023","unstructured":"Ostrom, Q. T. et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016\u20132020. Neuro Oncol. 25, iv1\u2013iv99 (2023).","journal-title":"Neuro Oncol."},{"key":"10612_CR3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel, C. et al. An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178, 835\u2013849 (2019).","journal-title":"Cell"},{"key":"10612_CR4","doi-asserted-by":"crossref","unstructured":"Venteicher, A. S. et al. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science 355, eaai8478 (2017).","DOI":"10.1126\/science.aai8478"},{"key":"10612_CR5","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807\u20131812 (2008).","journal-title":"Science"},{"key":"10612_CR6","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N. Engl. J. Med. 372, 2481\u20132498 (2015).","DOI":"10.1056\/NEJMoa1402121"},{"key":"10612_CR7","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/s41588-021-00927-7","volume":"53","author":"R Chaligne","year":"2021","unstructured":"Chaligne, R. et al. Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states. Nat. Genet. 53, 1469\u20131479 (2021).","journal-title":"Nat. Genet."},{"key":"10612_CR8","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/s41588-021-00926-8","volume":"53","author":"KC Johnson","year":"2021","unstructured":"Johnson, K. C. et al. Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response. Nat. Genet. 53, 1456\u20131468 (2021).","journal-title":"Nat. Genet."},{"key":"10612_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ccell.2015.07.012","volume":"28","author":"T Mazor","year":"2015","unstructured":"Mazor, T. et al. DNA methylation and somatic mutations converge on the cell cycle and define similar evolutionary histories in brain tumors. Cancer Cell 28, 307\u2013317 (2015).","journal-title":"Cancer Cell"},{"key":"10612_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature20123","volume":"539","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma. Nature 539, 309\u2013313 (2016).","journal-title":"Nature"},{"key":"10612_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41586-019-1775-1","volume":"576","author":"FP Barthel","year":"2019","unstructured":"Barthel, F. P. et al. Longitudinal molecular trajectories of diffuse glioma in adults. Nature 576, 112\u2013120 (2019).","journal-title":"Nature"},{"key":"10612_CR12","unstructured":"Malta, T. M. et al. The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen. Cancer Res. 84, 741\u2013756 (2023)."},{"key":"10612_CR13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","volume":"164","author":"M Ceccarelli","year":"2016","unstructured":"Ceccarelli, M. et al. Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164, 550\u2013563 (2016).","journal-title":"Cell"},{"key":"10612_CR14","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/j.cell.2022.04.038","volume":"185","author":"FS Varn","year":"2022","unstructured":"Varn, F. S. et al. Glioma progression is shaped by genetic evolution and microenvironment interactions. Cell 185, 2184\u20132199 (2022).","journal-title":"Cell"},{"key":"10612_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.1239947","volume":"343","author":"BE Johnson","year":"2014","unstructured":"Johnson, B. E. et al. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343, 189\u2013193 (2014).","journal-title":"Science"},{"key":"10612_CR16","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41588-021-00874-3","volume":"53","author":"E Kocakavuk","year":"2021","unstructured":"Kocakavuk, E. et al. Radiotherapy is associated with a deletion signature that contributes to poor outcomes in patients with cancer. Nat. Genet. 53, 1088\u20131096 (2021).","journal-title":"Nat. Genet."},{"key":"10612_CR17","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00401-015-1424-1","volume":"129","author":"P Wesseling","year":"2015","unstructured":"Wesseling, P., van den Bent, M. & Perry, A. Oligodendroglioma: pathology, molecular mechanisms and markers. Acta Neuropathol. 129, 809\u2013827 (2015).","journal-title":"Acta Neuropathol."},{"key":"10612_CR18","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","volume":"618","author":"A Gavish","year":"2023","unstructured":"Gavish, A. et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature 618, 598\u2013606 (2023).","journal-title":"Nature"},{"key":"10612_CR19","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/j.cell.2024.03.029","volume":"187","author":"AC Greenwald","year":"2024","unstructured":"Greenwald, A. C. et al. Integrative spatial analysis reveals a multi-layered organization of glioblastoma. Cell 187, 2485\u20132501 (2024).","journal-title":"Cell"},{"key":"10612_CR20","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41588-020-00726-6","volume":"52","author":"GS Kinker","year":"2020","unstructured":"Kinker, G. S. et al. Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity. Nat. Genet. 52, 1208\u20131218 (2020).","journal-title":"Nat. Genet."},{"key":"10612_CR21","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.cell.2023.02.017","volume":"186","author":"DD Liu","year":"2023","unstructured":"Liu, D. D. et al. Purification and characterization of human neural stem and progenitor cells. Cell 186, 1179\u20131194 (2023).","journal-title":"Cell"},{"key":"10612_CR22","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.neuron.2022.03.008","volume":"110","author":"JS Sadick","year":"2022","unstructured":"Sadick, J. S. et al. Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer\u2019s disease. Neuron 110, 1788\u20131805 (2022).","journal-title":"Neuron"},{"key":"10612_CR23","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41588-025-02167-5","volume":"57","author":"M Nomura","year":"2025","unstructured":"Nomura, M. et al. The multilayered transcriptional architecture of glioblastoma ecosystems. Nat. Genet. 57, 1155\u20131167 (2025).","journal-title":"Nat. Genet."},{"key":"10612_CR24","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.ccell.2024.03.008","volume":"42","author":"A Spitzer","year":"2024","unstructured":"Spitzer, A. et al. Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma. Cancer Cell 42, 904\u2013914 (2024).","journal-title":"Cancer Cell"},{"key":"10612_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101249","volume":"4","author":"E Blanco-Carmona","year":"2023","unstructured":"Blanco-Carmona, E. et al. Tumor heterogeneity and tumor\u2013microglia interactions in primary and recurrent IDH1-mutant gliomas. Cell Rep. Med. 4, 101249 (2023).","journal-title":"Cell Rep. Med."},{"key":"10612_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01175-6","volume":"15","author":"Y Wei","year":"2023","unstructured":"Wei, Y. et al. Stalled oligodendrocyte differentiation in IDH-mutant gliomas. Genome Med. 15, 24 (2023).","journal-title":"Genome Med."},{"key":"10612_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2004-5-6-226","volume":"5","author":"S Jones","year":"2004","unstructured":"Jones, S. An overview of the basic helix-loop-helix proteins. Genome Biol. 5, 226 (2004).","journal-title":"Genome Biol."},{"key":"10612_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.stem.2017.06.004","volume":"21","author":"NI Park","year":"2017","unstructured":"Park, N. I. et al. ASCL1 reorganizes chromatin to direct neuronal fate and suppress tumorigenicity of glioblastoma stem cells. Cell Stem Cell 21, 209\u2013224 (2017).","journal-title":"Cell Stem Cell"},{"key":"10612_CR29","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature08712","volume":"463","author":"MS Carro","year":"2010","unstructured":"Carro, M. S. et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 463, 318\u2013325 (2010).","journal-title":"Nature"},{"key":"10612_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ccell.2021.05.002","volume":"39","author":"T Hara","year":"2021","unstructured":"Hara, T. et al. Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma. Cancer Cell 39, 779\u2013792 (2021).","journal-title":"Cancer Cell"},{"key":"10612_CR31","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/s43018-022-00475-x","volume":"3","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets. Nat. Cancer 3, 1534\u20131552 (2022).","journal-title":"Nat. Cancer"},{"key":"10612_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28372-y","volume":"13","author":"N Abdelfattah","year":"2022","unstructured":"Abdelfattah, N. et al. Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat. Commun. 13, 767 (2022).","journal-title":"Nat. Commun."},{"key":"10612_CR33","volume":"6","author":"KS Patel","year":"2024","unstructured":"Patel, K. S. et al. Single-nucleus expression characterization of non-enhancing region of recurrent high-grade glioma. Neurooncol. Adv. 6, vdae005 (2024).","journal-title":"Neurooncol. Adv."},{"key":"10612_CR34","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ejca.2022.08.016","volume":"175","author":"CMS Tesileanu","year":"2022","unstructured":"Tesileanu, C. M. S., Vallentgoed, W. R., French, P. J. & van den Bent, M. J. Molecular markers related to patient outcome in patients with IDH-mutant astrocytomas grade 2 to 4: a systematic review. Eur. J. Cancer 175, 214\u2013223 (2022).","journal-title":"Eur. J. Cancer"},{"key":"10612_CR35","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41586-020-2209-9","volume":"580","author":"M Touat","year":"2020","unstructured":"Touat, M. et al. Mechanisms and therapeutic implications of hypermutation in gliomas. Nature 580, 517\u2013523 (2020).","journal-title":"Nature"},{"key":"10612_CR36","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg6045","volume":"7","author":"A Nikolic","year":"2021","unstructured":"Nikolic, A. et al. Copy-scAT: deconvoluting single-cell chromatin accessibility of genetic subclones in cancer. Sci. Adv. 7, eabg6045 (2021).","journal-title":"Sci. Adv."},{"key":"10612_CR37","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1158\/1078-0432.CCR-24-0562","volume":"30","author":"AM Nasser","year":"2024","unstructured":"Nasser, A. M. et al. CDKN2A\/B homozygous deletion sensitizes IDH-mutant glioma to CDK4\/6 inhibition. Clin. Cancer Res. 30, 2996\u20133005 (2024).","journal-title":"Clin. Cancer Res."},{"key":"10612_CR38","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00401-020-02226-7","volume":"140","author":"A Golebiewska","year":"2020","unstructured":"Golebiewska, A. et al. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology. Acta Neuropathol. 140, 919\u2013949 (2020).","journal-title":"Acta Neuropathol."},{"key":"10612_CR39","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/s41586-025-08633-8","volume":"640","author":"TE Miller","year":"2025","unstructured":"Miller, T. E. et al. Programs, origins and immunomodulatory functions of myeloid cells in glioma. Nature 640, 1072\u20131082 (2025).","journal-title":"Nature"},{"key":"10612_CR40","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S1470-2045(21)00090-5","volume":"22","author":"MJ van den Bent","year":"2021","unstructured":"van den Bent, M. J. et al. Adjuvant and concurrent temozolomide for 1p\/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study. Lancet Oncol. 22, 813\u2013823 (2021).","journal-title":"Lancet Oncol."},{"key":"10612_CR41","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","volume":"181","author":"F Klemm","year":"2020","unstructured":"Klemm, F. et al. Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells. Cell 181, 1643\u20131660 (2020).","journal-title":"Cell"},{"key":"10612_CR42","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1038\/s41591-025-03884-4","volume":"31","author":"KJ Drummond","year":"2025","unstructured":"Drummond, K. J. et al. Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial. Nat. Med. 31, 3451\u20133463 (2025).","journal-title":"Nat. Med."},{"key":"10612_CR43","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.ccell.2025.08.006","volume":"43","author":"J Tang","year":"2025","unstructured":"Tang, J. et al. Protein-based classification reveals an immune-hot subtype in IDH mutant astrocytoma with worse prognosis. Cancer Cell 43, 2136\u20132155 (2025).","journal-title":"Cancer Cell"},{"key":"10612_CR44","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1200\/JCO.2003.01.009","volume":"21","author":"JA Quinn","year":"2003","unstructured":"Quinn, J. A. et al. Phase II trial of temozolomide in patients with progressive low-grade glioma. J. Clin. Oncol. 21, 646\u2013651 (2003).","journal-title":"J. Clin. Oncol."},{"key":"10612_CR45","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","volume":"32","author":"Q Wang","year":"2017","unstructured":"Wang, Q. et al. Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell 32, 42\u201356 (2017).","journal-title":"Cancer Cell"},{"key":"10612_CR46","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41591-020-0844-1","volume":"26","author":"M Slyper","year":"2020","unstructured":"Slyper, M. et al. A single-cell and single-nucleus RNA-seq toolbox for fresh and frozen human tumors. Nat. Med. 26, 792\u2013802 (2020).","journal-title":"Nat. Med."},{"key":"10612_CR47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nprot.2014.006","volume":"9","author":"S Picelli","year":"2014","unstructured":"Picelli, S. et al. Full-length RNA-seq from single cells using Smart-seq2. Nat. Protoc. 9, 171\u2013181 (2014).","journal-title":"Nat. Protoc."},{"key":"10612_CR48","doi-asserted-by":"publisher","unstructured":"Chowdhury, T. et al. Tumor-initiating genetics and therapy drive divergent molecular evolution in IDH-mutant gliomas. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.07.11.664189 (2025).","DOI":"10.1101\/2025.07.11.664189"},{"key":"10612_CR49","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/annonc\/mdu479","volume":"26","author":"F Favero","year":"2015","unstructured":"Favero, F. et al. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data. Ann. Oncol. 26, 64\u201370 (2015).","journal-title":"Ann. Oncol."},{"key":"10612_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08200-y","volume":"10","author":"V Deshpande","year":"2019","unstructured":"Deshpande, V. et al. Exploring the landscape of focal amplifications in cancer using AmpliconArchitect. Nat. Commun. 10, 392 (2019).","journal-title":"Nat. Commun."},{"key":"10612_CR51","doi-asserted-by":"crossref","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e29 (2021).","DOI":"10.1016\/j.cell.2021.04.048"},{"key":"10612_CR52","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329\u2013337 (2019).","journal-title":"Cell Syst."},{"key":"10612_CR53","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"10612_CR54","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1471-2105-11-367","volume":"11","author":"R Gaujoux","year":"2010","unstructured":"Gaujoux, R. & Seoighe, C. A flexible R package for nonnegative matrix factorization. BMC Bioinformatics 11, 367 (2010).","journal-title":"BMC Bioinformatics"},{"key":"10612_CR55","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/s41588-025-02168-4","volume":"57","author":"A Spitzer","year":"2025","unstructured":"Spitzer, A. et al. Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomics. Nat. Genet. 57, 1168\u20131178 (2025).","journal-title":"Nat. Genet."},{"key":"10612_CR56","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782 (2019).","journal-title":"Nat. Biotechnol."},{"key":"10612_CR57","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14, 7 (2013).","journal-title":"BMC Bioinformatics"},{"key":"10612_CR58","doi-asserted-by":"crossref","unstructured":"Granja, J. M. et al. ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis. Nat. Genet. 53, 403\u2013411 (2021).","DOI":"10.1038\/s41588-021-00790-6"},{"key":"10612_CR59","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","volume":"180","author":"F Jacob","year":"2020","unstructured":"Jacob, F. et al. A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity. Cell 180, 188\u2013204 (2020).","journal-title":"Cell"},{"key":"10612_CR60","doi-asserted-by":"crossref","unstructured":"Johnson, K. C. et al. Single-nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4\/6 and mTOR inhibition in a phase 0\/1 trial of recurrent high-grade glioma. Neuro Oncol. 28, 659\u2013671 (2025).","DOI":"10.1093\/neuonc\/noaf257"},{"key":"10612_CR61","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1158\/2159-8290.CD-19-0329","volume":"9","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. The phenotypes of proliferating glioblastoma cells reside on a single axis of variation. Cancer Discov. 9, 1708\u20131719 (2019).","journal-title":"Cancer Discov."},{"key":"10612_CR62","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00401-024-02811-0","volume":"148","author":"SA Ghisai","year":"2024","unstructured":"Ghisai, S. A. et al. Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma. Acta Neuropathol. 148, 50 (2024).","journal-title":"Acta Neuropathol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10612-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10612-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10612-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:33:17Z","timestamp":1784723597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10612-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":62,"journal-issue":{"issue":"8124","published-print":{"date-parts":[[2026,7,23]]}},"alternative-id":["10612"],"URL":"https:\/\/doi.org\/10.1038\/s41586-026-10612-6","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"5 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.L.S. is an equity holder, scientific co-founder and advisory board member of Immunitas Therapeutics. I.T. is an advisory board member of Immunitas Therapeutics\u00a0and is\u00a0a co-founder and scientific advisor of Cellyrix Therapeutics. R.G.W.V. is a co-founder of and holds equity in Boundless Bio. F.B. has a next-of-kin employed by Bristol Myers Squibb. D.P.C. has received financial compensation from Boston Scientific (2025) and Servier (2023) for advisory input. He has also received financial compensation and travel reimbursement from the US NIH and DOD for clinical trial and grant review (2024). J.J.M. receives consulting fees from Servier. The authors declare that such activities have no relationship to the current study.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}